Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9796	Companies
196369	Keywords
127389	Articles
104407	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 10/16/2025 at 06:35, 3 months 18 days ago

Actor Pharmaceuticals et Megalabs s'associent pour la commercialisation du FYB203

Formycon AG Biosimilaire Eylea® Megalabs Acteur Pharmaceutique Commercialisation Du FYB203
BRIEF

published on 10/16/2025 at 06:35, 3 months 18 days ago

Actor Pharmaceuticals and Megalabs Partner for FYB203 Commercialization

Formycon AG Eylea® Biosimilar Actor Pharmaceuticals Megalabs FYB203 Commercialization
PRESS RELEASE

published on 10/16/2025 at 06:30, 3 months 18 days ago

Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Actor Pharmaceuticals and Megalabs to commercialize Formycon's Eylea biosimilar FYB203 in Australia and Latin America. Partnership agreements include upfront payments and royalties

Partnerships Commercialization Biosimilar Formycon Eylea
BRIEF

published on 10/02/2025 at 06:35, 4 months 1 day ago

Formycon Secures U.S. License for Aflibercept Biosimilar

Formycon AG U.S. Market Launch Aflibercept Biosimilar Regeneron Agreement Patent Dispute Resolution
BRIEF

published on 10/02/2025 at 06:35, 4 months 1 day ago

Formycon obtient une licence américaine pour le biosimilaire d'Aflibercept

Formycon AG Lancement Sur Le Marché Américain Biosimilaire D'Aflibercept Accord Regeneron Résolution Des Litiges En Matière De Brevets
PRESS RELEASE

published on 10/02/2025 at 06:30, 4 months 1 day ago

Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026

Formycon Regeneron Valorum Biologics Aflibercept Biosimilar Patent Disputes
BRIEF

published on 09/17/2025 at 16:00, 4 months 16 days ago

Formycon AG: Updated Research and Performance Forecast

Revenue Forecast Biosimilars Formycon FYB202 FYB206
BRIEF

published on 09/17/2025 at 16:00, 4 months 16 days ago

Formycon AG : Recherche et prévisions de performance actualisées

Prévisions De Revenus Formycon FYB202 Biosimilaires FYB206
PRESS RELEASE

published on 09/17/2025 at 15:55, 4 months 16 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates rating on Formycon AG (ISIN: DE000A1EWVY8) to Buy with a target price of €48. Analyst expects revenue to rebound in H2 and Q4 due to FYB202 and FYB206 developments

First Berlin Equity Research BUY Rating Formycon AG Update Target Price
BRIEF

published on 09/17/2025 at 06:35, 4 months 16 days ago

Horus Pharma Joins Formycon's Eylea® Biosimilar Commercialization

Commercialization Biosimilar Formycon Baiama Horus Pharma

Accesswire

Published on 02/03/2026 at 23:30, 31 minutes ago

FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 49 minutes ago

Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 1 hour 31 minutes ago

Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million
Published on 02/03/2026 at 22:25, 1 hour 36 minutes ago

VIDAA Selects Amdocs MarketONE to Power a New Generation of OTT Subscription and Streaming Bundles on Smart TVs
Published on 02/03/2026 at 22:15, 1 hour 46 minutes ago

Amdocs Introduces aOS: An Agentic Operating System for Telecommunications

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 20:57, 3 hours 4 minutes ago

EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 3 hours 24 minutes ago

Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 3 hours 56 minutes ago

KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026
Published on 02/03/2026 at 19:52, 4 hours 8 minutes ago

POS-Transaction in Own Shares
Published on 02/03/2026 at 19:50, 4 hours 11 minutes ago

Blockchain.com & Ondo Finance Launch Onchain Tokenized U.S. Stocks Across Europe

Les Echos

Published on 02/03/2026 at 19:18, 4 hours 42 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 6 hours 1 minute ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 6 hours 16 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 6 hours 16 minutes ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 17:45, 6 hours 16 minutes ago

Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)

View all LES ECHOS COMFI WIRE